QHR® high-rate primary cells are typically used in cardiac rhythm devices to treat tachycardia as well as other implantable applications where ampere-level pulse currents are required to provide effective therapy.
Our QHR hybrid-cathode battery technology is specifically engineered to provide maximum device performance and ensure longevity with minimal size.
When paired with QCAPS high voltage capacitors, QHR batteries provide the smallest, longest-lived, highest-energy power solutions for today’s tachycardia devices. Second-generation QHR batteries utilize the same reliable chemistry as previous generation QHR batteries delivering the most energy- and power-dense ICD battery solution available.
QHR batteries are available in custom-engineered configurations to meet application-specific needs.